Jasneet Kaur Khalsa

Jasneet Kaur Khalsa

Harvard University

H-index: 12

North America-United States

About Jasneet Kaur Khalsa

Jasneet Kaur Khalsa, With an exceptional h-index of 12 and a recent h-index of 9 (since 2020), a distinguished researcher at Harvard University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Editor's Note: Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

Potential Drivers of Acquired Resistance to Idelalisib in CLL Patients

Immune profiling of syngeneic murine and patient GBMs for effective translation of immunotherapies

Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL)

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

Jasneet Kaur Khalsa Information

University

Position

Dana Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT and Harvard

Citations(all)

451

Citations(since 2020)

403

Cited By

140

hIndex(all)

12

hIndex(since 2020)

9

i10Index(all)

12

i10Index(since 2020)

9

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Top articles of Jasneet Kaur Khalsa

Title

Journal

Author(s)

Publication Date

Editor's Note: Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas

Clinical Cancer Research

Sung Hugh Choi

Daniel W Stuckey

Sara Pignatta

Clemens Reinshagen

Jasneet Kaur Khalsa

...

2024/5/1

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Blood

Jasneet Kaur Khalsa

Justin Cha

Filippo Utro

Aishath Naeem

Ishwarya Murali

...

2023/8/3

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

Blood Cancer Journal

Deepti Gadi

Stephen P Martindale

Pui Yan Chiu

Jasneet Khalsa

Pei-Hsuan Chen

...

2023/2/2

Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

Nature communications

Deepak Bhere

Sung Hugh Choi

Pim van de Donk

David Hope

Kiki Gortzak

...

2022/5/19

Potential Drivers of Acquired Resistance to Idelalisib in CLL Patients

Blood

Saurabh Yadav

Jasneet Khalsa

Ishwarya Murali

Richard R Furman

Neil E Kay

...

2022/11/15

Immune profiling of syngeneic murine and patient GBMs for effective translation of immunotherapies

Jasneet Kaur Khalsa

Khalid Shah

2021/2/25

Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL)

Cancer Research

Ishwarya Murali

Justin Cha

Ignaty Leshchiner

Yanan Kuang

Kevin Vasquez

...

2021/7/1

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

Na Song

Hiroaki Wakimoto

Filippo Rossignoli

Deepak Bhere

Rachele Ciccocioppo

...

2021/6/1

Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia (cll)

Blood, The Journal of the American Society of Hematology

Ishwarya Murali

Siddha Kasar

Aishath Naeem

Svitlana Tyekucheva

Jasneet K Khalsa

...

2021/7/8

A role for cell-autocrine interleukin-2 in regulatory T-cell homeostasis

Gopalakrishnan Aneeshkumar Arimbasseri

Vineeta Bal

Anna George

Satyajit Rath

Amanpreet Singh Chawla

...

2020

Abstract LB-354: Immune phenotyping of diverse syngeneic brain tumors identifies critical tumor micro-environmental differences

Cancer Research

Jasneet K Khalsa

Joshua W Keegan

Nina Cheng

Joseph Driver

Ameen Chaudry

...

2020/8/15

Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types

Nature communications

Jasneet Kaur Khalsa

Nina Cheng

Joshua Keegan

Ameen Chaudry

Joseph Driver

...

2020/8/6

A role for cell‐autocrine interleukin‐2 in regulatory T‐cell homeostasis

Immunology

Amanpreet Singh Chawla

Jasneet Kaur Khalsa

Atika Dhar

Suman Gupta

Danish Umar

...

2020/7

Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed from the PD-L1 locus

Molecular Cell

Marco Mineo

Shawn M Lyons

Mykola Zdioruk

Niklas von Spreckelsen

Ruben Ferrer-Luna

...

2020/6/5

Abstract B46: The long noncoding RNA INCA1 is a novel regulator of PD-L1 expression in tumors

Cancer Immunology Research

Marco Mineo

Shawn M Lyons

Ruben Ferrer-Luna

Hirotaka Ito

Niklas von Spreckelsen

...

2020/3/1

See List of Professors in Jasneet Kaur Khalsa University(Harvard University)